News about "Forma Life Sciences"

Cycle Pharma Selects Forma Life Sciences for US Supply of FDA-Approved CAVHANZA

Cycle Pharma Selects Forma Life Sciences for US Supply of FDA-Approved CAVHANZA

Cycle Pharmaceuticals selects Forma Life Sciences to establish US commercial supply of Food and Drug Administration (FDA)-approved CAVHANZA (nilotinib) for Philadelphia chromosome-positive CML patients.

Forma Life Sciences | 13/08/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members